Linping Wu
Overview
Explore the profile of Linping Wu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
647
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bai W, Xu J, Gu W, Wang D, Cui Y, Rong W, et al.
Nat Commun
. 2025 Jan;
16(1):474.
PMID: 39774694
UHRF1 maintains DNA methylation by recruiting DNA methyltransferases to chromatin. In mouse, these dynamics are potently antagonized by a natural UHRF1 inhibitory protein STELLA, while the comparable effects of its...
2.
Ci H, Jie J, Zhang G, Wu L, Wang Z, Sun J
Int J Nanomedicine
. 2024 Dec;
19:13839-13855.
PMID: 39735323
Purpose: Successful regeneration of cranial defects necessitates the use of porous bone fillers to facilitate cell proliferation and nutrient diffusion. Open porous microspheres, characterized by their high specific surface area...
3.
Liu X, Li Z, Li X, Wu W, Jiang H, Zheng Y, et al.
Nat Commun
. 2024 Oct;
15(1):8932.
PMID: 39414822
Antibody-dependent enhancement (ADE) is a potential concern for the development of Zika virus (ZIKV) vaccines. Cross-reactive but poorly neutralizing antibodies, usually targeting viral pre-membrane or envelope (E) proteins, can potentially...
4.
Liu Y, Huang Y, He G, Guo C, Dong J, Wu L
Int J Mol Sci
. 2024 Sep;
25(18).
PMID: 39337651
Lipid nanoparticles (LNPs) have emerged as leading non-viral carriers for messenger RNA (mRNA) delivery in clinical applications. Overcoming challenges in safe and effective mRNA delivery to target tissues and cells,...
5.
Hou J, Jie J, Wei X, Shen X, Zhao Q, Chai X, et al.
J Nanobiotechnology
. 2024 Jul;
22(1):449.
PMID: 39080658
No abstract available.
6.
Bai L, Wu L, Zhang C, Liu Z, Ma L, Ni J, et al.
Mater Today Bio
. 2024 Apr;
26:101056.
PMID: 38660474
Diabetic foot ulcer (DFU) is a highly morbid complication in patients with diabetes mellitus, necessitating the development of innovative pharmaceuticals to address unmet medical needs. Sodium ion (Na) is a...
7.
Ma Q, Li M, Ma L, Zhang C, Zhang H, Zhong H, et al.
Front Immunol
. 2023 Jun;
14:1195299.
PMID: 37292197
Introduction: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant has rapidly spread around the globe. With a substantial number of mutations in its Spike protein, the SARS-CoV-2 Omicron...
8.
Yu J, Hu C, Dai Z, Xu J, Zhang L, Deng H, et al.
Int Immunopharmacol
. 2023 Apr;
119:110203.
PMID: 37094543
Background: The treatment of rheumatoid arthritis (RA) related to the disease activity. However, the lack of highly sensitive and simplified markers limits the evaluation of disease activity. We sought to...
9.
Zhu M, Bai L, Liu X, Peng S, Xie Y, Bai H, et al.
J Immunother Cancer
. 2023 Jan;
10(12).
PMID: 36600555
Background: Colony-stimulating factor 1 receptor (CSF1R), a classic tyrosine kinase receptor, has been identified as a proto-oncogene in multiple cancers. The CSF1/CSF1R axis is essential for the survival and differentiation...
10.
Guo Y, Wu L, Qiu F
Org Lett
. 2022 Nov;
24(45):8370-8374.
PMID: 36350067
A highly diastereo- and enantioselective formal [4 + 2] cyclization of α,β-unsaturated ketoesters with nitroalkenes through a tandem asymmetric Michael addition-intramolecular Henry reaction under dihydroquinine-based phase-transfer catalysis, leading to a...